Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | SALWAN DISTRIBUTORS | Awarded | 1 | ₹8,593.20 |
| 2 | Schedule 2 | SUKUN PHARMALikely | RA Ended | 1 | ₹2,412 |
| 3 | Schedule 3 | SMPL LIFE SCIENCES PRIVATE LIMITEDLikely | RA Ended | 1 | ₹6,682.20 |
| 4 | Schedule 4 | AMAR MEDICOLikely | RA Ended | 1 | ₹13,275 |
| 5 | Schedule 5 | MEDICAL EQUIPMENT AND ENGG COMPANY | Awarded | 1 | ₹55,158.96 |
Tender Value
₹18.8 L
EMD Value
Exempted
Closing Date
23 Oct 2024, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
DGLP RE 17
6950172
GEM/2024/B/5440229
Two Packet Bid
Linagliptin 5 mg,Thyroxine Sodium 0 point 025 mg Tab,Neostigmine 0 point 5 mg 1 ml Inj,Succinylchlo
15 days
Ladakh; Leh Ladakh
Item wise evaluation
PRODUCT
6 documents required · 6 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Linagliptin 5 mg | Leh | 13,860 | 15 days | |
| Thyroxine Sodium 0 point 025 mg Tab | Leh | 12,060 | 15 days | - |
| Neostigmine 0 point 5 mg 1 ml Inj | Leh | 1,806 | 15 days | |
| Succinylchloline Chloride 50 mg per ml 2 ml Inj | Leh | 750 | 15 days | |
| Ciprofloxacin HCL 0 point 3 percent plus Dexamethasone 0 point 1 percent bott of 5 ml | Leh | 8,868 | 15 days | |
| Cyclosporine eye drop 0 point 05 percent bott of 3 ml | Leh | 60 | 15 days | |
| Fluconazole 0 point 3 percent w or v bott of 5 ml | Leh | 360 | 15 days | |
| Hydroxy Methyl Cellulose 2 percent 2 ml Inj | Leh | 246 | 15 days | |
| Pilocarpine Intracameral Inj 0 point 5 percent Pilocarpine Nitrate Intra ocular Inj without preservative amp of 01 ml each | Leh | 60 | 15 days | - |
| Povidone 5 percent eye drop bott of 5 ml | Leh | 486 | 15 days | |
| Predinisolone acetate 1 percent w or v bott of 5 ml | Leh | 516 | 15 days | - |
| Sodium Chloride 6 percent w or w ointment Tube of 3 gm | Leh | 216 | 15 days | |
| Sodium Chloride eye drop 5 percent 5 ml bott | Leh | 2,664 | 15 days | |
| Azelaic Acid 20 percent cream tube of 15 gm | Leh | 66 | 15 days | |
| Cream Luliconazole tubr of 15 gm | Leh | 3,150 | 15 days | |
| Timolol maleate eye drop 0 point 5 percent bott of 5 ml | Leh | 564 | 15 days | - |
| Trypan Blue 0 point 6 percent in vial of 1 ml Inj | Leh | 120 | 15 days | |
| Atropine sulphate oint 1 percent Tube of 3 gm | Leh | 60 | 15 days | - |
| Dexamethasone 0 point 1 percent eye drop bott of 5 ml | Leh | 66 | 15 days | |
| Bimatoprost 0 point 03 percent bott of 3 ml | Leh | 186 | 15 days | |
| Dorzolamide 2 percent plus Timolol 0 point 5 percent bott of 5 ml eye drops | Leh | 192 | 15 days | |
| Olapatadine Hydrochloride 0 point 1 percent Ophthalmic Sol Bott of 5ml | Leh | 1,416 | 15 days | |
| Syp Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg Sodium Citrate 50 to 85 mg per 5 ml bottle of 100 ml | Leh | 18,012 | 15 days | |
| Prochlorperazine Maleate 5 mg Tab | Leh | 6,366 | 15 days | |
| Chloramphenicol 5 percent w or v Clotrimazole 1 percent w or v Betamethasone 0 point 25 percent w or v Lignocaine HCL 2 percent w or v in bott of 5 ml | Leh | 2,412 | 15 days | - |
| Pseudoepjidrine 60 mg with Tripolidine 2 point 5 mg Tab | Leh | 5,130 | 15 days | |
| Tab Nasal Decongestant Phenyl Propanolamine with Chlorpheniramine | Leh | 8,412 | 15 days | - |
| Xylometazoline HCI 0 point 05 percent w or v nasal solution for paed use bott of 10 ml | Leh | 3,150 | 15 days | |
| Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg | Leh | 67,410 | 15 days |
Exempted
23 Oct 2024
2 Oct 2024
23 Oct 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6950172.pdf
GEM_BID
item_specification_dglp_re-17_0001_2024-09-25-17-04-12_f74c912d8425deee89c12bbe2910f90b.pdf
BOQ
dglp_re-17_2024-09-25-17-04-12_0bf8f17dce82aaf2c370a35f73fa8f58.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .